Gail M. Farfel's Insider Trades & SAST Disclosures
Gail M. Farfel's most recent trade in Durect Corp was a trade of 5,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on Sept. 25, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gail M. Farfel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Durect Corp | Gail M. Farfel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2024 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| ProMIS Neurosciences Inc. | Gail M. Farfel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 53,192 | 53,192 | - | - | Warrants to purchase Common Shares | |
| ProMIS Neurosciences Inc. | Gail M. Farfel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 53,192 | 55,192 | - | - | Common Shares | |
| Durect Corp | Gail M. Farfel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| Tectonic Therapeutic Inc. | Gail M. Farfel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 17,643 | 17,643 | - | - | Stock Option (Right to Buy) | |
| ProMIS Neurosciences Inc. | Gail M. Farfel | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.94 per share. | 14 Dec 2022 | 1,000 | 2,000 | - | 4.9 | 4,940 | Common Shares |
| ProMIS Neurosciences Inc. | Gail M. Farfel | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.70 per share. | 06 Dec 2022 | 1,000 | 1,000 | - | 5.7 | 5,700 | Common Share |
| ProMIS Neurosciences Inc. | Gail M. Farfel | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2022 | 208,334 | 208,334 | - | - | Option (right to buy) | |
| Durect Corp | Gail M. Farfel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Tectonic Therapeutic Inc. | Gail M. Farfel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Gail M. Farfel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Durect Corp | Gail M. Farfel | Director | Purchase of securities on an exchange or from another person at price $ 0.41 per share. | 16 May 2022 | 29,911 | 100,000 (0%) | 0% | 0.4 | 12,201 | Common Stock |
| Durect Corp | Gail M. Farfel | Director | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 16 May 2022 | 25,300 | 70,089 (0%) | 0% | 0.4 | 9,811 | Common Stock |
| Durect Corp | Gail M. Farfel | Director | Purchase of securities on an exchange or from another person at price $ 0.41 per share. | 10 May 2022 | 2,339 | 24,089 (0%) | 0% | 0.4 | 950 | Common Stock |
| Durect Corp | Gail M. Farfel | Director | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 09 May 2022 | 17,500 | 17,500 (0%) | 0% | 0.4 | 6,906 | Common Stock |
| Durect Corp | Gail M. Farfel | Director | Purchase of securities on an exchange or from another person at price $ 0.40 per share. | 09 May 2022 | 4,250 | 21,750 (0%) | 0% | 0.4 | 1,679 | Common Stock |
| Durect Corp | Gail M. Farfel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Tectonic Therapeutic Inc. | Gail M. Farfel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 17,438 | 17,438 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Gail M. Farfel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2020 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| Durect Corp | Gail M. Farfel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 55,000 | 55,000 | - | - | Non-Qualified Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges